Biotech Investors & VC Firms in Europe
1049 firms in this list, with a median first check of $500K. 293 of them lead rounds. Generated from verified public data and updated continuously.
QUBIS
BelfastPre-Seed–Seed$12.7K – $127K
11 people
Sunstone Capital
FrederiksbergSeed–Series B
12 people
Brightlands Venture Partners
GeleenSeed–Series B$540K – $2.2M
14 people
Big Pi Ventures
AthensSeed–Growth$540K – $3.2M
19 people
Creator Fund
LondonPre-Seed–Seed$1.1M
22 people
AdBio partners
ParisPre-Seed–Series A
23 people
RSJ Investments SICAV a.s.
PrahaSeed–Growth
28 people
MVM Life Science Partners
LondonSeed–Growth$20M – $100M
20 people
Gateway Trustee GmbH
WienSeed$11K
15 people
Sarsia Management AS
BergenSeed–Series A$200K – $500K
13 people
Enterprise Investors Sp. z o. o.
WarsawSeries B–Growth$21.6M – $81M
27 people
Practica Capital
VilniusPre-Seed–Series A$324K – $3.2M
9 people
Wellcome Trust
LondonSeries B–Late Stage
17 people
Oxford University Innovation
OxfordPre-Seed–Seed
22 people
imec.xpand
LeuvenSeed–Series B$270K – $5.4M
12 people
Balnord Sp. z o.o.
LuxembourgPre-Seed–Seed$550K – $3.3M
14 people
Northstar Ventures
Newcastle upon TynePre-Seed–Seed$38.1K – $1.3M
17 people
ACT Venture Partners
AmsterdamPre-Seed–Seed$500K – $1.5M
19 people
Asabys Partners
BarcelonaSeed–Growth
18 people
Invivo Capital Partners
BarcelonaPre-Seed–Series A$2.2M – $4.4M
18 people
Vespucci Partners
BudapestSeed–Series A$650K – $4.9M
21 people
Amino Collective
BerlinPre-Seed–Series A$216K – $1.6M
8 people
Debiopharm Innovation Fund
LausanneSeed–Series A$1M – $5M
17 people
BioMedPartners
BaselSeed–Series A$648K – $6.5M
18 people
Related lists
Investors & VC Firms in North America (13326)Investors & VC Firms in United States (12318)Investors & VC Firms in Europe (6083)AI & Machine Learning Investors & VC Firms (5352)Investors & VC Firms in Global (5318)Fintech Investors & VC Firms (5140)Healthtech Investors & VC Firms (4657)SaaS Investors & VC Firms (4528)Enterprise Software Investors & VC Firms (4424)Crypto & Web3 Investors & VC Firms (4140)
Data sourced from public filings and firms' own websites — see our methodology.






































































































